Bruker Corporation (BRKR)
Automate Your Wheel Strategy on BRKR
With Tiblio's Option Bot, you can configure your own wheel strategy including BRKR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BRKR
- Rev/Share 22.6086
- Book/Share 16.5151
- PB 2.431
- Debt/Equity 0.7556
- CurrentRatio 1.7296
- ROIC -0.0148
- MktCap 6010785960.0
- FreeCF/Share 0.2849
- PFCF 138.8172
- PE -699.2
- Debt/Assets 0.2995
- DivYield 0.0051
- ROE -0.004
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | BRKR | Wolfe Research | Peer Perform | Outperform | -- | $60 | Dec. 10, 2025 |
| Initiation | BRKR | Goldman | -- | Sell | -- | $40 | Dec. 9, 2025 |
| Initiation | BRKR | Rothschild & Co Redburn | -- | Buy | -- | $60 | Nov. 20, 2025 |
| Downgrade | BRKR | Citigroup | Buy | Neutral | -- | $40 | May 22, 2025 |
| Initiation | BRKR | Guggenheim | -- | Buy | -- | $72 | Dec. 19, 2024 |
| Initiation | BRKR | UBS | -- | Neutral | -- | $66 | Dec. 10, 2024 |
| Upgrade | BRKR | Goldman | Sell | Neutral | -- | $60 | Dec. 5, 2024 |
| Initiation | BRKR | Barclays | -- | Overweight | -- | $75 | Oct. 15, 2024 |
| Downgrade | BRKR | Wolfe Research | Outperform | Peer Perform | -- | -- | Sept. 30, 2024 |
| Initiation | BRKR | Wells Fargo | -- | Overweight | -- | $78 | Aug. 28, 2024 |
News
Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum
Published: February 23, 2026 by: Business Wire
Sentiment: Neutral
ORLANDO, Fla.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be unveiled at the 2026 Advances in Genome Biology and Technology (AGBT) General Meeting. These updates highlight Bruker's category leadership in spatial biology and its commitment to delivering best‑in‑class solutions across DNA, RNA, and protein. The Bruker Spatial Biology division will launch several new products, introduce expanded capabilities,.
Read More
Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology
Published: February 23, 2026 by: Business Wire
Sentiment: Neutral
ST. LOUIS--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and GlycoScape™ software now support database-independent PTM discovery, confident proteoform characterizatio.
Read More
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the Stock
Published: February 18, 2026 by: Zacks Investment Research
Sentiment: Neutral
Examine the evolution of Bruker's (BRKR) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Read More
Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down
Published: February 16, 2026 by: Zacks Investment Research
Sentiment: Negative
BRKR's Q4 EPS miss estimates as margins plunge and shares fall 2.7% despite a revenue beat, while the 2026 outlook targets 4%-5% sales growth.
Read More
Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript
Published: February 12, 2026 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation (BRKR) Q4 2025 Earnings Call Transcript
Read More
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 12, 2026 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Bruker (BRKR) Q4 Earnings Miss Estimates
Published: February 12, 2026 by: Zacks Investment Research
Sentiment: Negative
Bruker (BRKR) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.76 per share a year ago.
Read More
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Negative
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Allspring Common Stock Fund Q4 2025 Performance Review
Published: January 28, 2026 by: Seeking Alpha
Sentiment: Neutral
In the fourth quarter, Revolve's stock rose as its revenue met expectations with a 4.4% year-over-year increase. In fiscal second quarter 2026, Haemonetics delivered strong performance, raising guidance and posting margin gains that signal operational discipline. CHWY shares declined in September after the company reported elevated selling, general, and administrative expenses.
Read More
Artisan Small Cap Fund Q4 2025 Portfolio Activity
Published: January 23, 2026 by: Seeking Alpha
Sentiment: Neutral
During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investment campaigns in Integer Holdings and SharkNinja during the quarter.
Read More
Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Published: January 12, 2026 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Read More
Should You Continue to Hold BRKR Stock in Your Portfolio?
Published: December 26, 2025 by: Zacks Investment Research
Sentiment: Negative
Bruker's innovation pipeline and acquisitions support long-term growth, but macro pressures and funding risks cloud the stock's near-term outlook.
Read More
RI Research Instruments Announces Major Orders for Enabling Technology for the Gamma-Ray Source of the Extreme Light Infrastructure (ELI)
Published: December 22, 2025 by: Business Wire
Sentiment: Neutral
BERGISCH GLADBACH, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--RI Research Instruments, a company that is majority-owned by Bruker Corporation (Nasdaq: BRKR), today announced orders for key components and enabling subsystems for the research gamma ray source of the Extreme Light Infrastructure – Nuclear Physics (ELI-NP) at the Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH) in Romania. The total value of these ELI contracts is approximately €35 million (more than USD $40 million), w.
Read More
Bruker (BRKR) Up 17.1% Since Last Earnings Report: Can It Continue?
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
Read More
Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation ( BRKR ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Joe Kostka Frank Laukien - Chairman, CEO & President Gerald Herman - Executive VP & CFO Conference Call Participants Puneet Souda - Leerink Partners LLC, Research Division Avantika Dhabaria - BofA Securities, Research Division Tycho Peterson - Jefferies LLC, Research Division Luke Sergott - Barclays Bank PLC, Research Division Subhalaxmi Nambi - Guggenheim Securities, LLC, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Joshua Waldman - Cleveland Research Company LLC Douglas …
Read More
Earnings Preview: Bruker (BRKR) Q3 Earnings Expected to Decline
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Negative
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Is the Options Market Predicting a Spike in Bruker Stock?
Published: October 23, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to BRKR stock based on the movements in the options market lately.
Read More
BRKR Shares Climb After Securing New Orders for Its NMR Systems
Published: October 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker stock climbs after securing $10M in federally funded NMR orders from top U.S. research institutions.
Read More
Bruker Announces Orders for NIH- and NSF-Funded NMR Systems from New York Structural Biology Center, University of Delaware and Northwestern University
Published: October 03, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new orders for advanced Nuclear Magnetic Resonance (NMR) instrumentation from the New York Structural Biology Center (NYSBC), the University of Delaware and Northwestern University. Supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF), these high-performance systems will enable leading research teams to pursue breakthroughs across a wide range of scientific research, dr.
Read More
Bruker (BRKR) Up 3.6% Since Last Earnings Report: Can It Continue?
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
Read More
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative
BRKR's Q2 profit drops sharply, revenues decrease, and weak demand leads to guidance cuts despite cost-saving plans.
Read More
Unlocking Bruker (BRKR) International Revenues: Trends, Surprises, and Prospects
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
Explore Bruker's (BRKR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Read More
Bruker Corporation (BRKR) Q2 2025 Earnings Call Transcript
Published: August 04, 2025 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation (NASDAQ:BRKR ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Frank H. Laukien - Chairman, CEO & President Gerald N.
Read More
Bruker (BRKR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Bruker (BRKR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Bruker (BRKR) Misses Q2 Earnings Estimates
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Negative
Bruker (BRKR) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.52 per share a year ago.
Read More
Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025
Published: July 21, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported revenue year-over-year. Bruker estimates that its non-GAAP organic revenue in the second quarter of 2025 declined approximately 7% year-over-year, with constant-exchange rate revenue declining approximately 3%. Second quarter 2025 bookings reflect weak academic demand, as w.
Read More
BRKR Stock Gains Following the Multi-System Advanced Packaging Order
Published: June 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker ships and installs its 15th InSight WLI system as part of a 27-optical metrology unit order tied to AI chip packaging demand.
Read More
New Strong Sell Stocks for June 23rd
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Negative
ARCC, BIDU and BRKR have been added to the Zacks Rank #5 (Strong Sell) List on June 23 2025.
Read More
Bruker Stock Set to Gain From Acquisition of Austria's biocrates
Published: June 10, 2025 by: Zacks Investment Research
Sentiment: Positive
BRKR strengthens its MS-based metabolomics platform with the biocrates deal, boosting investor sentiment.
Read More
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
Published: June 03, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied MS) division will present a powerful lineup of innovations at the 73rd American Society for Mass Spectrometry (ASMS) Conference, taking place June 1–5, 2025, in Baltimore, Maryland. These developments reflect Bruker's continued investment in applied markets, particularly in therapeutic drug monitoring (TDM), drugs of abuse (DoA) analysis and environmental analysis. Br.
Read More
About Bruker Corporation (BRKR)
- IPO Date 2000-08-04
- Website https://www.bruker.com
- Industry Medical - Devices
- CEO Frank H. Laukien
- Employees 11396